Global Hemoglobin A1C Testing Market Forecast to 2028 – Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing

DUBLIN, Dec. 1, 2023 /PRNewswire/ — The “Global Hemoglobin A1C Testing Market, Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering.

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results.

By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products.

Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Key Topics Covered:

HbA1c Testing Overview

Key CompetitorsGlobal Diabetes Highlights, 2021Number of People with Diabetes, 2021-2045Top 10 Countries or Territories for Number of AdultsGrowth MetricsGrowth DriversGrowth RestraintsForecast AssumptionsRevenue ForecastRevenue Forecast AnalysisRevenue Forecast by RegionRevenue Forecast By SettingRevenue Forecast by End UsersRevenue Forecast by TechnologyPricing Trends and AnalysisKey Pricing Strategies Adopted by PlayersFuture Aspect of PricingGlobal HbA1c Testing Market – Notable ActivitiesGlobal HbA1c Testing Reimbursement PathwaysCompetitive Environment

Companies to Watch – Lab and POC HbA1c Testing

Abbott LaboratoriesRoche DiagnosticsSiemens HealthineersBeckman CoulterTosoh CorporationBio-Rad LaboratoriesEKF DiagnosticsErba Diagnostics, Inc.Diazyme LaboratoriesPTS DiagnosticsTrinity BiotechCompetitive Mapping by HbA1c Offering Parameters

Growth Opportunity Summary

Growth Opportunity 1 – Tailoring HbA1c Testing Approaches to Individual Patient CharacteristicsGrowth Opportunity 2 – Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c TestingGrowth Opportunity 3 – Capturing Opportunities in Growing Diabetes Care MarketsGrowth Opportunity 4 – Diabetes HbA1c Screening for Better Care and Management

For more information about this report visit https://www.researchandmarkets.com/r/nac9vf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-hemoglobin-a1c-testing-market-forecast-to-2028—advancements-in-poct-for-accurate-affordable-and-user-friendly-hba1c-testing-302003055.html

SOURCE Research and Markets